Back to 
Macquarie Group Ltd.
Macquarie Group Ltd.
KRYS
Showing 0 of 11 quarters
Position history for Macquarie Group Ltd.'s holdings in Krystal Biotech, Inc.
No. Macquarie Group exited its KRYS (Krystal Biotech) position in Q4 2022. Its Q3 2022 13F listed 382 shares worth $44,000. Macquarie Group first reported KRYS in Q2 2020 and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.